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Abstract
Background: The genus Corynebacterium is composed of Gram-positive bacteria that are widely distributed
throughout the environment; these bacteria are also part of the normal microbiota of human skin and mucous
membranes. Multiple studies have shown that species of this genus, including C. striatum, become pathogenic to
humans under special conditions. Our aim was to determine the characteristics of clinical multiresistant strains of C.
striatum that were isolated in our geographical region, to determine their diversity, and to compare them with the
type strain and with related species. We studied fifty-two strains of C. striatum isolated from different hospitals from
Mallorca, Spain, mainly from the Hospital Joan March in Bunyola, Mallorca. Most of the strains were isolated from
sputum cultures of respiratory samples from patients with chronic obstructive pulmonary disease. To gain further
insight into the genetic diversity of the strains, we analysed several housekeeping genes and other genes
associated with antibiotic resistance. Strains were also characterised phenotypically by their antibiotic resistance
profiles and by MALDI-TOF mass spectrometry analysis.
Results: The ITS1 region, gyrA and rpoB were chosen as the appropriate genes in the C. striatum genome to study
the genetic diversity of C. striatum species and to discriminate between strains. After analysing these three genes,
four sequence types (ST2, ST4, ST1 and ST11) were found to be the most abundant. Splits tree analysis of the
strains demonstrated that these clinical isolates did not share any alleles with the type strain of the species.
Recombination was detected within all of the C. striatum isolates, and different clonal populations were detected
within the samples.
Conclusions: Our results demonstrate that the isolates were best identified using gene-based molecular methods;
using these methods, the isolated strains were determined to be different from the type strain of C. striatum. The
ITS1 region and the gyrA and rpoB genes were selected because of their variability and were the most useful tools
for discriminating between strains. The phenotype and antibiotype characteristics of the strains did not seem
suitable for typing purposes. MALDI-TOF mass spectrometry can be a useful method for identifying and
discriminating between C. striatum strains.
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Background
The genus Corynebacterium includes pathogens, non-
pathogenic environmental bacteria, and saprophytic spe-
cies. The most widely known pathogenic species is C.
diphtheriae. C. diphtheriae, endemic in many countries,
represents a global health problem because of the out-
breaks it has caused in recent decades, as documented
by the WHO. Characterisation of the strains is needed
to obtain a better understanding and microbiological
and epidemiological control [1]. In addition to C.
diphtheriae, other potentially pathogenic species of the
genus are C. amycolatum, C. jeikeium, C. macginleyi
and C. urealyticum [2-4]. C. xerosis has also been
described as an unusual pathogen [5]. Outbreaks of
nosocomial infections have been reported for C. pseudo-
diphtheriticum [6-8] and, remarkably, C. striatum [9-12].
C. striatum is widely disseminated in the environment
and constitutes part of the normal microbiota of the
skin and mucous membranes. However, it is potentially
pathogenic in specific circumstances, including in infec-
tions of patients with lasting chronic diseases, frequent
and prolonged hospitalisations, exposure to antibiotics
against Gram-negative bacteria (which facilitates the
selection of Gram positives), the use of invasive proce-
dures and the presence of organic obstructive patholo-
gies [11,12]. Any circumstance wherein there is
increased longevity of disease or chronic disease
increases the risk of infection and results in infections
occurring more frequently.
Although the significance and prevalence of C. stria-
tum as a causative agent of disease are not well under-
stood, this organism has been responsible for a variety
of different infections [11,13]. Most C. striatum infec-
tions reported to date have been found in respiratory
samples, with the vast majority of the strains being mul-
tiresistant to antibiotics. Leonard et al. and Bradenburg
et al. studied the presence of C. striatum in intensive
care units, postulating the existence of person-to-person
transmission [9,10]. Otsuka et al. [11] described the fre-
quent isolation of C. striatum in long-stay advanced dis-
eases that were subjected to repeated antibiotic courses.
In 2007, Renom et al. [12] described the first nosoco-
mial outbreak of this bacterium in patients with chronic
obstructive pulmonary diseases (COPD). All of the
strains identified in this outbreak were antibiotic
multiresistant.
To understand the source of an outbreak, it is very
important to have reliable identification and typing
methods for the responsible bacteria. Several studies
have tried to accomplish this objective [10,11], but none
of them employ a methodology for the identification
and typing of bacterial strains. The main aim of our
study is to determine the parameters for characterisation
of clinical multiresistant strains of C. striatum from spu-
tum cultures isolated from the respiratory samples of
COPD patients in our geographical region; we aim to
determine the diversity of the strains and to compare
the isolates with the C. striatum type strain and with
related species.
All strains were characterised phenotypically by RapID
CB® Plus strips (Remel Laboratories, Lenexa, KS), by
their antibiotic susceptibility profile and also by genomic
profiling (ERIC-PCR, Enterobacterial Repetitive Inter-
genic Consensus-PCR). These experimental methods
provided limited resolution. To gain further insight into
the diversity of the C. striatum strains, a multilocus
sequence typing (MLST) scheme was developed to iden-
tify significant intraspecies genetic diversity. MLST, pro-
posed in 1998 by Maiden et al. [14], has shown that
nucleotide variation within several core metabolic genes
provides portable, reproducible and high-resolution data
appropriate for evolutionary and epidemiological investi-
gations. The strains were also analysed using matrix-
assisted laser desorption ionisation time-of-flight
(MALDI-TOF) mass spectrometry. MALDI-TOF has
been reported by several studies as a powerful tool with
accurate and reproducible results for rapid identification
of clinical isolates in the microbiology laboratory. This
method is simple, rapid, easy to perform, inexpensive
and may ultimately replace routine phenotypic assays
[15,16].
Methods
C. striatum culture collection
A total of 52 strains of C. striatum (collected between
May 2006 and June 2009) were studied from three
hospitals located in Mallorca, Spain. All of these
strains were analysed and compared with the type
strain of C. striatum ATCC 6940T and the type strain
of C. amycolatum CCUG 35685T, the closest-related
species; the isolated strains were also compared with
two strains from the culture collection of the Göteborg
University (CCUG) that were characterised in a first
approach as C. striatum strains (one from a clinical
origin and the other environmental). All Corynebacter-
ium strains were isolated and cultured on Columbia
agar with 5% sheep blood (bioMérieux). Prior to culti-
vation, all samples were Gram-stained to determine
the samples that could be discarded; strains that were
not representative of the lower respiratory tract and
the ones contaminated with microbiota from the upper
respiratory tract, according to the Murray and
Washington criteria, were not used [17]. The cultiva-
tion and incubation of the plates were performed
under routine laboratory conditions. All of the strains
are shown as Additional file 1: Table S1.
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Phenotypical and antibiotic susceptibility
characterisations
The 56 strains were analysed phenotypically by RapID
CB Plus® strips, and their antibiogram profiles were
established by E-test assay (AB Biodisk, Solna, Sweden)
on Mueller-Hinton agar plates supplemented with 5% of
blood (bioMérieux, Marcy d’Etoile, France), according to
CLSI recommendations [18].
DNA extraction: PCR amplification and DNA sequencing
Bacterial genomic DNA for PCR amplifications was
obtained as previously described [19]. All C. striatum
strains were compared by the ERIC-PCR technique,
using the primers ERIC1R (5’-ATGTAAGCTCCTGGG-
GATTCAC-3’) and ERIC2 (5’-AAGTAAGT-
GACTGGGGTGAGCG-3’) [20]. The housekeeping
genes, 16S rDNA, ITS1 (internal transcribed spacer 1),
gyrB, hsp65, rpoB and sodA, were amplified and
sequenced for the 56 strains. Two genes codifying for
antibiotic resistance, aphA and ermX, were also ampli-
fied and sequenced for these strains. Three other primer
sets codifying for antibiotic resistances (cmx, repB and
tetA) were also tested but did not produce an amplicon.
The list of primers is indicated as Additional file 2:
Table S2 [21-25]. PCR amplification and sequence reac-
tion was performed as previously described [19].
Allele diversity, nucleotide diversity and statistical
analysis
Allele and nucleotide diversities were calculated from
the gene sequences with the DnaSP package, version
3.51 [26]. For identification purposes, distinct allele
sequences were assigned arbitrary allele numbers for
each locus. For each isolate, the combination of alleles
obtained at each locus defined its allelic profile. Each
allelic profile constitutes a sequence type (ST), and iso-
lates with identical profiles belonged to the same ST.
Clustering of STs was performed with the Sequence
Type Analysis and Recombinational Tests (START) pro-
gram [27]. The matrix of pair-wise distances between
the allelic profiles was converted to NEXUS files, and
the split decomposition was analysed with the SplitsTree
software program, vs. 4 [28]. Splits tree allowed
researchers to visualise clustering within the population
and to detect recombination between STs. The nucleo-
tide sequences determined in this study for the different
alleles of each locus have been deposited in the EMBL
database under the accession numbers HE586270 to
HE586309.
Analysis by MALDI-TOF mass spectrometry
Matrix-assisted linear desorption/ionisation-time-of-
flight mass spectrometry (MALDI-TOF MS) analyses for
all strains were performed at Anagnostec, GmbH, Ger-
many [29], as described Scotta et al. [30].
Results
Phenotypic characterisation and antibiotic susceptibility
tests of the isolates
All colonies were pale yellow in colour, nonhemolytic,
catalase positive and oxidase negative. The strains were
identified by the RapID CB Plus® strips as C. striatum
(51 strains with a confidence level between 85.54% -
99.97%), C. pseudodiphtheriticum (2 strains with a 100%
of confidence level), or C. amycolatum (1 strain with a
confidence level of 51.26%) [Additional file 3: Table S3].
All isolates were susceptible to vancomycin and resistant
to cefotaxime and ciprofloxacin, whereas susceptibilities
to other antibiotics tested were heterogeneous (Addi-
tional file 4: Table S4). The type strain of C. amycola-
tum was susceptible to all the antibiotics tested. The C.
striatum type strain was susceptible to all of the antibio-
tics except cefotaxime. The two isolates that were ana-
lysed from the CCUG were sensitive to antibiotics.
ERIC-PCR
Groupings based on the most similar fingerprint type of
ERIC-PCR generated seven different profiles (repre-
sented by strains 2, 11, 15, 19, 31, 60 and 70) for C.
striatum strains. The profile of the type strain of C.
striatum was different from those of the clinical isolates;
differences between the isolates were also observed (see
Additional file 5: Figure S1).
Multilocus sequence typing
Seven genes were determined for most of the strains
studied. The 16S rRNA gene was excluded from the
exhaustive analysis because of the high conservation
between all of the strains studied; it was only used as a
control to check the authenticity of the strains. Clinical
isolates 16 and 17, characterised by phenotypical meth-
ods as C. pseudodiphtheriticum, were affiliated with the
C. striatum species as determined by molecular meth-
ods. The ermX, aphA and sodA genes were also
excluded from the analysis because of the high conser-
vation between all strains.
The ITS1, gyrA and rpoB genes were used to discrimi-
nate between strains, although the genes differed at few
nucleotide changes within the sequences. The sequence
analysis of ITS1 demonstrated the presence of more
than one rrn operon in most of the strains, which was
not appreciable in the agarose gel as a double band but
was detectable in the sequence electropherogram. The
presence of more than one operon was checked by clon-
ing of four PCR products (data not shown). Analysis of
the gyrA and rpoB genes revealed that the variability
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Table 1 STs at the eight loci examined in the C. striatum and C. amycolatum strains studied
Strain 16Sr DNA ITS1 gyrA rpoB hsp65 sodA ermX aphA ST*
2 1 3 2 2 1 1 1 1 1
7 1 3 2 2 1 1 1 1 1
9 1 6 2 2 1 - 1 1 2
11 1 1 3 2 1 1 1 1 3
12 1 1 3 2 1 - 1 1 3
14 1 6 2 2 1 1 1 1 2
15 1 4 3 2 1 - 1 1 4
16 1 4 3 2 1 1 1 1 4
17 1 2 2 2 1 1 1 1 5
18 1 4 3 2 1 - 1 1 4
19 1 1 3 2 1 - 1 1 3
21 1 6 2 2 1 1 1 1 2
23 1 6 2 2 1 1 1 1 2
24 1 2 2 2 1 1 1 - 5
25 1 3 2 2 1 1 1 1 1
26 1 6 2 2 1 1 1 1 2
28 1 7 3 2 1 1 1 1 6
29 1 5 2 2 1 1 1 1 7
30 1 4 3 4 1 1 1 1 8
31 1 6 2 2 1 1 1 1 2
35 1 6 2 2 1 - 1 1 2
36 1 6 2 2 1 1 1 1 2
41 1 6 2 2 1 1 1 1 2
42 1 6 2 2 1 - 1 1 2
43 1 3 2 2 1 - 1 - 1
44 1 4 3 2 1 - 1 1 4
46 1 3 2 2 1 1 1 1 1
47 1 4 3 2 1 1 1 1 4
48 1 2 2 2 1 1 1 - 5
50 1 4 3 2 1 1 1 1 4
51 1 10 4 2 1 - 1 - 9
53 1 2 2 2 1 1 1 1 5
54 1 3 2 2 1 1 1 - 1
55 1 6 2 2 1 1 1 1 2
56 1 1 3 2 1 - 1 1 3
57 1 4 3 2 1 1 1 1 4
58 1 4 3 2 1 1 1 1 4
59 1 4 3 2 1 - 1 1 4
60 1 4 3 2 1 1 1 1 4
61 1 12 3 3 1 1 1 - 10
62 1 7 3 3 1 - 1 1 11
63 - 7 3 3 1 - 1 1 11
64 1 7 3 3 1 1 1 - 11
65 1 7 3 3 1 - 1 - 11
66 1 4 3 4 1 1 1 1 8
67 1 7 3 3 1 1 1 - 11
68 1 7 3 3 1 - 1 - 11
69 1 9 5 4 2 1 1 - 12
70 2 13 7 6 3 2 1 1 13
71 1 11 4 2 1 1 1 1 14
73 1 4 3 4 1 1 1 - 8
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between different Corynebacterium species occurred
throughout the gene, while the variability in the clinical
C. striatum isolates was confined to certain areas near
the beginning of the gene.
Distinct allele sequences were assigned arbitrary allele
numbers for each locus (Table 1). Calculated allele and
nucleotide diversities are shown in Table 2. The number
of polymorphic sites and the haplotype and nucleotide
diversity were not calculated for the ITS1 region
because, in most cases, more than one operon was
detected. 16S rDNA, ermX, aphA, sodA and hsp65 were
not appropriate genes for studying the genetic diversity
of the strains, although these genes could be used to dif-
ferentiate between Corynebacterium species. gyrA and
rpoB were appropriate genes to study genetic diversity,
with 116 and 39 polymorphic sites, respectively. In the
ITS1 region, the most abundant alleles were 4 (23.2%), 6
(19.6%), 7 (12.5%), 3 (10.7%), and alleles 1 and 2 (7.1%).
Each one of the other alleles for ITS1, representing
19.6% of the population, is represented by a single
strain. For the gyrA gene, two alleles (number 2 and 3)
were predominant (90%). For the rpoB gene, allele 2 is
the most abundant and is found in 39 strains (69.6%).
Considering these three genes, four STs were the most
abundant: ST2, ST4, ST1 and ST11, occurring in 11, 10,
6 and 6 strains, respectively.
To determine the possible lateral gene transfers occur-
ring in the population of Corynebacterium strains stu-
died and taking into account the ITS1, gyrB and rpoB
gene allelic profiles, a splits tree was constructed for all
analysed strains (Figure 1, panel A) and only with the C.
striatum strains (Figure 1, panel B). Some strains have
two or three identical genes. Type strains of C. striatum
and C. amycolatum did not share any allele, and recom-
bination was detected between all of the C. striatum iso-
lates. Different clonal populations could be detected, as
shown in Figure 1.
Bacterial analysis by MALDI-TOF mass spectrometry
In the MALDI-TOF MS cluster analysis, the Corynebac-
terium species could be clearly differentiated from one
another with less than 50% similarity. MALDI-TOF MS
profiles for all of the strains studied have been included
as Additional files 6: Figure S2. All the strains analysed
clustered in four different groups (with similarities
higher than 60%): the cluster of C. striatum included
Table 1 STs at the eight loci examined in the C. striatum and C. amycolatum strains studied (Continued)
74 1 8 3 4 1 - 1 2 15
C. striatum ATCC 6940T 1 17 1 1 1 - 1 - 16
C. amycolatum CCUG 35685T 5 14 3 7 4 - - - 17
CCUG 39137 3 15 3 6 3 - - 2 18
CCUG 44705 4 16 6 5 1 - - - 19
* ST number was obtained taking into account only three of the eight loci analyzed (ITS1 region, gyrA, and rpoB genes)
Table 2 Genetic diversity of the selected loci among the Corynebacterium strains analysed
No. of
strains
Locus Fragment
length (bp)£
No. of
alleles
Haplotype (gene)
diversity ± SD
No. of
polymorphic
sites
Avg number of nucleotide
differences
Nucleotide
diversity ± SD
56 (48) 16S
rDNA
872 5 (1) 0.722 ± 0.159 71 (0) 31.972 0.037 ± 0.007
56 (49) ITS1¥ 360¥ 17 (10) - - - -
56 (49) gyrA 200 7 (3) 0.604 ± 0.040 (0.527 ±
0.001)
39 (3) 2.452
(1.073)
0.012 ± 0.006 (0.005
± 0.000)
56 (49) rpoB 380 7 (3) 0.498 ± 0.076
(0.379 ± 0.079)
116 (4) 11.551 (0.912) 0.0314 ± 0.012
(0.002 ± 0.000)
56 (49) hsp65 287 4 (1) 0.138 ± 0.062 (0 ± 0) 62 (0) 6.199
(0)
0.022 ± 0.011
(0 ± 0)
35 (32) sodA 295 2 (1) 0.057 ± 0.053 (0 ± 0) 64 (0) 3.657
(0)
0.012 ± 0.011
(0 ± 0)
53 (49) ermX 367 1 (1) 0 ± 0
(0 ± 0)
0 (0) 0
(0)
0 ± 0
(0 ± 0)
41 (38) aphA 333 2 (2) 0.095 ± 0.061 (0.053 ±
0.049)
1 (1) 0.095
(0.053)
0.0003 ± 0.0002 (0 ±
0)
The values corresponding only to clinical strains of C. striatum are given within brackets
£ The number indicated the length of the sequenced fragment used for the polymorphic analysis
¥ The number of polymorphic sites, and the haplotype and nucleotide diversity was not calculated for the ITS1 region because in most cases more than one
operon was detected. The number of alleles was established directly from the alignment
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most of the clinical isolates and the type strain of C.
striatum, and the cluster of C. amycolatum included the
type strain, isolate CCUG 39137, the clinical isolate 70
(similarity higher than 60%), and two branches, includ-
ing a single strain, the clinical isolate 69 and the envir-
onmental Corynebacterium CCUG 44705. The duplicate
Figure 1 Splits tree showing the distribution of all of sequence types obtained. Splits tree was based on the ITS1, gyrB and rpoB genes
allelic profile, for all analysed strains (panel A), and only for the C. striatum strains (panel B). The circles indicated the sequence types
represented by more than one strain. The size of the circle is proportional to the number of strains included in each sequence type.
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spectra for each strain analysed clustered at 60% similar-
ity or higher. At a 70% similarity level, three subclusters
could be distinguished in the C. striatum branch. Iso-
lates 16 and 17 were identified as C. pseudodiphtheriti-
cum by the RapID CB Plus® strips, the method
routinely used for identification in clinical laboratories,
but they clustered within the C. striatum group in the
MALDI-TOF analysis, in accordance with the sequen-
cing analysis. These data further support that MALDI-
TOF MS is an appropriate tool to differentiate and dis-
criminate species, even at the level of expression of the
most abundant cellular proteins.
Discussion
Strains of C. striatum isolated from cultures of sputum
of respiratory samples from patients with COPD were
studied in order to find possible differences between
them and the type strain. In general, this group of
organisms is well identified by current phenotypic meth-
ods, but in some cases, there is a lack of specificity that
may result in ambiguous or even erroneous identifica-
tion. Correct identification of bacteria remains critical
for the detection of outbreaks in specific populations of
patients and for the surveillance of bacteria within
patients.
Phenotypic characterisation and antibiotic-resistance
profiles did not clearly distinguish between C. striatum
strains. All strains were identifiable by the RapID CB
Plus® strips system, with three different identifications
being generated. All identifications had confidence levels
higher than 85.54%. Antibiotic-resistance profiles for C.
striatum clinical isolates were heterogeneous in the dif-
ferent antibiotics tested, whereas the type strains of C.
amycolatum and C. striatum, as well as the external
controls analysed, were mainly susceptible to the anti-
biotics tested.
Differences within clinical C. striatum isolates were
identified with PCR amplification and the sequencing of
several genes. Of all the genes analysed, the ITS1 region
and the gyrA and rpoB genes, due to their variability,
were the most adequate to discriminate between strains,
although ITS1 did not allow for calculations of genetic
diversity because of the presence of more than one rrn
operon. These genes were more polymorphic than the
other genes tested. The analyses provided an appropriate
identification of C. striatum strains and allowed for dis-
tinguishing between clinical isolates. Molecular analysis
allows species discrimination, unlike phenotypic analysis,
which sometimes misidentifies strains.
The 56 strains represent distinct allele combinations
(19 STs, considering only three genes: ITS1, gyrA and
rpoB); 11, 10, 6, and 6 strains showed identical allelic
profiles (sequetypes 2, 4, 1 and 11, corresponding to the
allelic profiles 6-2-2, 4-3-2, 3-2-2 and 7-3-3). All of the
C. striatum clinical isolates were different from the type
strain, and recombination events could be detected
between them, supporting the hypothesis that these
groups represent genetically similar strains.
The identification of strains based on molecular meth-
ods was also confirmed by MALDI-TOF mass spectro-
metry. The bacteria identified were exactly the same
with both methods. As suggested by Seng et al. [15],
MALDI-TOF may represent a rapid, inexpensive, alter-
native assay for identification of bacteria at the species
level. These results were also in agreement with data
obtained by Bittar et al. [8]. Our results suggest that
MALDI-TOF mass spectrometry could also be a benefi-
cial tool for discrimination of bacterial strains discrimi-
nation below the species level, but it is not as efficient
as the molecular analysis for identifying strains. Further
studies to evaluate the typing power should be
performed.
Conclusions
In summary, our results demonstrate that the isolates
obtained were best identified with gene-based molecular
methods and that they were different from the type
strain of C. striatum. Additionally, the ITS1 region and
the gyrA and rpoB genes are the most useful tools to
discriminate between strains because of their variability,
unlike the phenotype and antibiotype, which are not sui-
table for this purpose. Our results suggest that MALDI-
TOF mass spectrometry is a good tool for C. striatum
identification and for discriminating bacterial strains
below the species level.
Additional material
Additional file 1: Table S1. List of isolates analysed, their origin and
sample type. External strains for comparison purposes have been
included in the study: the type strains C. amycolatum CCUG 35685T and
C. striatum ATCC 6940T, as well as two strains of C. striatum with different
origins, CCUG 39137 (from a human wound) and CCUG 44705 (tobacco
industry).
Additional file 2: Table S2. Primers used for performing the molecular
analysis of the 56 Corynebacterium strains.
Additional file 3: Table S3. Phenotypic results of RapID CB Plus®® tests
for the different strains analysed.
Additional file 4: Table S4. Antibiotic susceptibility pattern of each
strain analysed. The antibiotics tested for all strains were penicillin (PEN),
imipenem (IMI), erythromycin (ERI), rifampicin (RIF), tetracycline (TET),
vancomycin (VAN), ciprofloxacin (CIP), gentamicin (GEN), cefotaxime
(CEF), and trimethoprim-sulfamethoxazole (TRI). R, resistant; I,
intermediate; S, susceptible.
Additional file 5: Figure S1. ERIC-PCR patterns of the different C.
striatum clinical isolates analysed. The number on the top of the lane
corresponds to the number of clinical isolate studied; CsT, C. striatum
ATCC 6940T. M1, Marker lE/H; M2, marker 100 bp.
Additional file 6: Figure S2. SARAMIS cluster analysis of all
Corynebacterium strains isolated.
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